Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Animal models for liver disease – A practical approach for translational research
Yulia A. Nevzorova, Zoé Boyer-Díaz, Francisco Javier Cubero, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 2, pp. 423-440
Open Access | Times Cited: 189

Showing 1-25 of 189 citing articles:

Hepatic inflammatory responses in liver fibrosis
Linda Hammerich, Frank Tacke
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 10, pp. 633-646
Closed Access | Times Cited: 282
Role of liver sinusoidal endothelial cells in liver diseases
Jordi Gracia‐Sancho, Esther Caparrós, Anabel Fernández‐Iglesias, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 6, pp. 411-431
Closed Access | Times Cited: 251
A Systematic Review of Animal Models of NAFLD Finds High‐Fat, High‐Fructose Diets Most Closely Resemble Human NAFLD
Yu Ri Im, Harriet Hunter, Dana de Gracia Hahn, et al.
Hepatology (2021) Vol. 74, Iss. 4, pp. 1884-1901
Open Access | Times Cited: 119
Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis
Junliang Kuang, Jieyi Wang, Yitao Li, et al.
Cell Metabolism (2023) Vol. 35, Iss. 10, pp. 1752-1766.e8
Open Access | Times Cited: 114
Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localize to fibrotic areas and limit NASH
Tim Hendrikx, Florentina Porsch, Máté G. Kiss, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 5, pp. 1373-1385
Closed Access | Times Cited: 111
Physiological and pathological roles of lipogenesis
Yong Geun Jeon, Ye Young Kim, Gung Lee, et al.
Nature Metabolism (2023) Vol. 5, Iss. 5, pp. 735-759
Closed Access | Times Cited: 96
Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis
Jie Tong, Xiu-Ting Lan, Zhen Zhang, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 5, pp. 1014-1028
Closed Access | Times Cited: 91
Animal Models for the Study of Human Disease
Sherry J. Morgan, Julie A. Hutt, Radhakrishna Sura
(2023), pp. 241-264
Closed Access | Times Cited: 64
A Guide to Pathophysiology, Signaling Pathways, and Preclinical Models of Liver Fibrosis
Marjia Sultana, Md Asrarul Islam, Rhema Khairnar, et al.
Molecular and Cellular Endocrinology (2025), pp. 112448-112448
Closed Access | Times Cited: 1
Metabolic and alcohol-associated liver disease (MetALD): a representation of duality
Hector Leal-Lassalle, Olga Estévez-Vázquez, Francisco Javier Cubero, et al.
npj gut and liver. (2025) Vol. 2, Iss. 1
Open Access | Times Cited: 1
Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease
Zoé Boyer-Díaz, Peio Aristu-Zabalza, María Andrés‐Rozas, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 5, pp. 1188-1199
Open Access | Times Cited: 118
In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal
Pierre‐Antoine Soret, Julie Magusto, Chantal Housset, et al.
Journal of Clinical Medicine (2020) Vol. 10, Iss. 1, pp. 36-36
Open Access | Times Cited: 95
Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research
Christina‐Maria Flessa, Narjes Nasiri‐Ansari, Ioannis Kyrou, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15791-15791
Open Access | Times Cited: 65
Pathophysiology and therapeutic options for cirrhotic portal hypertension
Sergi Guixé‐Muntet, Sergio Quesada‐Vázquez, Jordi Gracia‐Sancho
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 7, pp. 646-663
Closed Access | Times Cited: 10
Longitudinal Magnetic Resonance Imaging with ROS‐Responsive Bilirubin Nanoparticles Enables Monitoring of Nonalcoholic Steatohepatitis Progression to Cirrhosis
Wonsik Jung, Muhammad Asaduddin, Hyeongseop Keum, et al.
Advanced Materials (2024) Vol. 36, Iss. 24
Closed Access | Times Cited: 8
Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides
Lucia Kořínková, Veronika Pražienková, Lucie Černá, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 66
Organoids and Spheroids as Models for Studying Cholestatic Liver Injury and Cholangiocarcinoma
Keisaku Sato, Wenjun Zhang, Samira Safarikia, et al.
Hepatology (2020) Vol. 74, Iss. 1, pp. 491-502
Open Access | Times Cited: 51
Experimental liver models: From cell culture techniques to microfluidic organs‐on‐chip
Michela Anna Polidoro, Erika Ferrari, Simona Marzorati, et al.
Liver International (2021) Vol. 41, Iss. 8, pp. 1744-1761
Open Access | Times Cited: 49
Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction
Antonio Segovia‐Zafra, Daniel E. Di Zeo-Sánchez, Carlos Lopez‐Gómez, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 12, pp. 3685-3726
Open Access | Times Cited: 44
Protective effects of fucoidan against ethanol-induced liver injury through maintaining mitochondrial function and mitophagy balance in rats
Huichao Zhao, Shuang Liu, Hui Zhao, et al.
Food & Function (2021) Vol. 12, Iss. 9, pp. 3842-3854
Closed Access | Times Cited: 40
Transcriptional and Epigenetic Regulation of Monocyte and Macrophage Dysfunction by Chronic Alcohol Consumption
Delphine C. Malherbe, Ilhem Messaoudi
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 36
Liver regeneration: Cellular origin and molecular mechanisms
Ru Chih C. Huang, Xin Zhang, Jordi Gracia‐Sancho, et al.
Liver International (2022) Vol. 42, Iss. 7, pp. 1486-1495
Closed Access | Times Cited: 35
Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2
Samar A. Antar, Mohamed A. Saleh, Ahmed A. Al‐Karmalawy
Life Sciences (2022) Vol. 309, pp. 121048-121048
Open Access | Times Cited: 31
A mouse model of hepatic encephalopathy: bile duct ligation induces brain ammonia overload, glial cell activation and neuroinflammation
Wouter Claeys, Lien Van Hoecke, Anja Geerts, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Recent advances in liver‐on‐chips: Design, fabrication, and applications
Linjie Qiu, Bin Kong, Tiantian Kong, et al.
Smart Medicine (2023) Vol. 2, Iss. 1
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top